Frontiers in antibiotic alternatives for Clostridioides difficile infection

       Clostridioides difficile is considered a threat to public health owing to increases in treatment failure over the past few years. Current antibiotic treatment options are highly limited. Therefore, alternative strategies are critical. Herein, we review recent advances in alternative therapeutics, including the development of new chemical entities, fecal microbiota transplantation, pre- and pro-biotic, antitoxin antibodies, use of bacteriophages, and vaccines. We also highlight the concerns, limitations, and directions for each of these developments.

Reference:

Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Frontiers in antibiotic alternatives for Clostridioides difficile infection. World J Gastroenterol. 2021 Nov 14;27(42):7210-7232. doi: 10.3748/wjg.v27.i42.7210. PMID: 34876784; PMCID: PMC8611198.

FreeBPG-logoDOI: 10.3748/wjg.v27.i42.7210

 

Download the article at Relevant SDGs
Research_Tj code Relevant SDGs-3
BC investigator
Tavan Janvilisri Prof.Tavan Janvilisri Dr. Supapit Wongkuna (Ph.D. graduate)
Tanaporn Phetruen (Ph.D. student)
Wichuda Phothichaisri (Ph.D. student)
Supakan Panturat (M.Sc. graduate)
Dr. Methinee Pipatthana (Ph.D. graduate)